Mead Johnson Nutrition Co. Expected to Earn FY2016 Earnings of $3.43 Per Share (MJN)
Mead Johnson Nutrition Co. (NYSE:MJN) – Analysts at Credit Agricole SA dropped their FY2016 EPS estimates for Mead Johnson Nutrition in a research report issued to clients and investors on Tuesday. Credit Agricole SA analyst M. Lavery now forecasts that the brokerage will post earnings per share of $3.43 for the year, down from their prior estimate of $3.45. Credit Agricole SA has a “Underperform” rating and a $77.00 price objective on the stock. Credit Agricole SA also issued estimates for Mead Johnson Nutrition’s FY2018 earnings at $3.75 EPS.
Mead Johnson Nutrition (NYSE:MJN) last released its quarterly earnings data on Thursday, October 27th. The company reported $0.87 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.86 by $0.01. The business earned $937.50 million during the quarter, compared to analysts’ expectations of $933.43 million. Mead Johnson Nutrition had a net margin of 13.26% and a negative return on equity of 119.05%. The firm’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same period in the prior year, the company earned $0.77 EPS.
A number of other research firms have also commented on MJN. Deutsche Bank AG set a $88.00 price objective on shares of Mead Johnson Nutrition and gave the company a “hold” rating in a research report on Sunday, July 24th. Susquehanna reiterated a “hold” rating and set a $90.00 target price on shares of Mead Johnson Nutrition in a research report on Wednesday, September 7th. Citigroup Inc. lifted their target price on shares of Mead Johnson Nutrition from $100.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, July 25th. JPMorgan Chase & Co. upgraded shares of Mead Johnson Nutrition from a “neutral” rating to an “overweight” rating and set a $105.00 target price for the company in a research report on Tuesday, July 26th. Finally, BMO Capital Markets reiterated an “outperform” rating and set a $97.00 target price on shares of Mead Johnson Nutrition in a research report on Friday, September 23rd. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $88.33.
Mead Johnson Nutrition (NYSE:MJN) traded down 0.65% during trading on Thursday, reaching $71.89. 317,345 shares of the company were exchanged. The company has a market capitalization of $13.28 billion, a P/E ratio of 26.71 and a beta of 1.43. The firm’s 50-day moving average is $77.07 and its 200 day moving average is $83.14. Mead Johnson Nutrition has a one year low of $65.53 and a one year high of $94.40.
In other news, Director Anna C. Catalano sold 656 shares of the business’s stock in a transaction on Monday, October 31st. The shares were sold at an average price of $74.99, for a total transaction of $49,193.44. Following the sale, the director now owns 8,796 shares in the company, valued at approximately $659,612.04. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.50% of the company’s stock.
Several hedge funds have recently made changes to their positions in the stock. The Manufacturers Life Insurance Company acquired a new stake in shares of Mead Johnson Nutrition during the third quarter worth approximately $158,430,000. William Blair Investment Management LLC purchased a new position in shares of Mead Johnson Nutrition during the second quarter worth about $142,077,000. FMR LLC boosted its position in shares of Mead Johnson Nutrition by 11.8% in the second quarter. FMR LLC now owns 13,045,067 shares of the company’s stock worth $1,183,840,000 after buying an additional 1,378,877 shares during the last quarter. Waddell & Reed Financial Inc. boosted its position in shares of Mead Johnson Nutrition by 47.0% in the second quarter. Waddell & Reed Financial Inc. now owns 4,274,094 shares of the company’s stock worth $387,874,000 after buying an additional 1,367,163 shares during the last quarter. Finally, Bank of Montreal Can purchased a new position in shares of Mead Johnson Nutrition during the second quarter worth about $101,332,000. Hedge funds and other institutional investors own 98.73% of the company’s stock.
Mead Johnson Nutrition Company Profile
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.
Receive News & Stock Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related stocks with our FREE daily email newsletter.